Human Mesenchymal Stem Cells Impact Th17 and Th1 Responses Through a Prostaglandin E2 and Myeloid-Dependent Mechanism

Human mesenchymal stem cells (hMSCs) are being increasingly pursued as potential therapies for immune-mediated conditions, including multiple sclerosis. Although they can suppress human Th1 responses, they reportedly can reciprocally enhance human Th17 responses. Here, we investigated the mechanisms...

Descripción completa

Detalles Bibliográficos
Autores principales: Rozenberg, Ayal, Rezk, Ayman, Boivin, Marie-Noëlle, Darlington, Peter J., Nyirenda, Mukanthu, Li, Rui, Jalili, Farzaneh, Winer, Raz, Artsy, Elinor A., Uccelli, Antonio, Reese, Jane S., Planchon, Sarah M., Cohen, Jeffrey A., Bar-Or, Amit
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AlphaMed Press 2016
Materias:
Cell-Based Drug Development, Screening, and Toxicology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070498/
https://www.ncbi.nlm.nih.gov/pubmed/27400792
http://dx.doi.org/10.5966/sctm.2015-0243

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5070498/
https://www.ncbi.nlm.nih.gov/pubmed/27400792
http://dx.doi.org/10.5966/sctm.2015-0243

Ejemplares similares